Liver Donor Match: Who Is Most Likely to Be a Match, and How a Living Donor Match Is Determined
The best living liver donor is the safest one, not the first to volunteer. A match is decided in sequence: a compatible blood group (or an ABO-incompatible protocol), a graft at least 0.8% of the recipient’s body weight while leaving the donor at least 30% of their own liver, a liver without significant fat, good general health, and an independent psychological assessment confirming a free decision.
— Dr Chetan Kalal, DM Hepatology, Gleneagles Hospital Mumbai
Key takeaways
- In India the large majority of liver transplants use a living donor, so “who should donate” is the central question for most families — and the answer is rarely whoever spoke first.
- Blood group is only the opening gate. An incompatible group is not a dead end: ABO-incompatible transplant with pre-operative desensitisation, or a swap with another family, are both established options in India.
- Two volume numbers decide most cases: the graft should be at least 0.8% of the recipient’s body weight, and the donor must keep at least 30% of their own liver. A willing, blood-compatible donor can still be ruled out by this arithmetic.
- Significant fatty liver is the commonest reason a young, healthy, motivated volunteer is declined. Many programmes reject donors with more than mild steatosis.
- Every donor is assessed psychologically by a clinician independent of the recipient’s team. “I have no choice” is a reason to pause, not to proceed.
- Age is a factor, not the deciding one. In my practice carefully selected donors up to 58 have donated safely after extended evaluation.
In most of the world, “waiting for a liver” means waiting for a deceased donor. In India it usually means something else: a family member stepping forward. The large majority of liver transplants performed here use a living donor, which means the central question is not “when will an organ become available” but “who in this family can safely give one, and will it work.”
When a family first hears that living donor transplant is possible, the question they ask is almost never “what are the criteria”. It is “who should it be?” The honest answer: not necessarily whoever offers first. In practice it is often the youngest adult child who volunteers instantly, while an older relative — an uncle, an aunt — hangs back, quietly assuming the younger generation should step up. That instinct, to defer or to rush forward out of duty, has nothing to do with who is the safer, more suitable donor. Sometimes the person who waited is the one who should have gone first.
This article is about two things families need to understand together: who is most likely to be a match, and how the transplant team actually determines it. For the donor’s own questions — the operation, the verified risks, how the liver regrows, recovery, who the law allows to donate — read my companion post on living liver donation: risks, recovery and eligibility. I will not repeat it here.
The first volunteer is not automatically the best donor
A spouse offers because they cannot imagine life without their partner. An adult child feels it is their duty. A sibling has watched the disease progress for years and steps in quietly. All of it understandable. None of it determines who is medically or psychologically right for this.
Donor selection rests on objective evaluation, not on who spoke up first or who feels most responsible. The goal is never finding a donor. It is finding the safest donor — and two outcomes matter equally: the recipient receives a well-functioning graft, and the donor recovers fully and returns to a healthy life.
How is a living liver donor match determined?
The match is built in steps, simplest and cheapest first, so that a donor who will not qualify is spared the later tests. Each step protects one of the two people on the table.
Step 1: Blood group compatibility
The starting point is ABO blood type. An identical or compatible group between donor and recipient is the simplest path forward.
An incompatible group is not an automatic dead end. ABO-incompatible (ABOi) liver transplant is a real option in selected patients, using a desensitisation protocol before surgery to lower the recipient’s anti-blood-group antibodies. The published results are now good: the largest single-centre series, 235 adult ABOi living donor transplants from Seoul, reported three-year patient survival of 92.3%, comparable to the centre’s 1,301 compatible transplants, and a meta-analysis of nine studies and 3,922 patients found no difference in one-, three- or five-year survival — though ABOi recipients had more biliary complications, more antibody-mediated rejection and more CMV infection. Indian centres report the same pattern, with biologically related donors doing marginally better than unrelated ones. In my own programme, outcomes in appropriately selected, desensitised ABOi cases have run in the 80–85% range — not identical to a compatible match, but a genuine option when a family has no compatible donor and time is against them.
The other route around a blood-group mismatch is a swap: two families, each with a willing but incompatible donor, exchange donors. Indian centres have now reported 259 liver exchange transplants, almost all two-way swaps done for ABO incompatibility. It is medically simple and logistically demanding, and it is worth asking about before accepting an ABOi protocol.
Step 2: Liver volume — the two numbers that decide most cases
The portion of liver donated has to be large enough to meet the recipient’s metabolic demands, and small enough that the donor’s remaining liver is safe. What follows is arithmetic from the CT volumetry, not a judgement call, and a willing, blood-compatible donor can still be ruled out here if the arithmetic does not work.
The recipient’s number is the graft-to-recipient weight ratio (GRWR): the weight of the graft divided by the recipient’s body weight. The 2023 ILTS consensus, which Indian centres co-authored, recommends a GRWR of at least 0.8% (or a graft at least 40% of the recipient’s standard liver volume). Below that, the risk of “small-for-size syndrome” — a graft too small to cope — climbs; in a recent international series of grafts at or below 0.6%, more than a third of recipients developed it. Experienced centres do transplant smaller grafts, with portal-flow modulation and careful recipient selection, but 0.8% remains the line most programmes plan around.
The donor’s number is the remnant: the share of their own liver they keep. Published programme criteria from high-volume centres set this at a minimum of 30% of the donor’s total liver volume, and some programmes demand more. If giving the recipient a large enough graft would leave the donor below the threshold, the answer is no, however much they want to help. A large recipient and a small donor is the commonest way this fails.
Step 3: Liver quality — fat and anatomy
Blood tests, then imaging, then if needed a biopsy answer one question: is this liver healthy enough to split? Significant steatosis (fatty liver) is the single commonest reason a young, otherwise healthy volunteer is declined, because fat impairs both halves — the graft functions poorly and the donor’s remnant regenerates poorly. Thresholds vary by programme: the University of Tokyo protocol, for example, rejects donors with more than 10% macroscopic steatosis, and a Korean series of older donors accepted only “no or mild” fatty liver. Where the fat is modest and the donor is motivated, a supervised period of weight loss and re-imaging is often the right answer rather than a flat refusal.
The CT and MRCP also map the arteries, portal vein, hepatic veins and bile ducts. Variant anatomy is common and most of it is manageable in experienced hands, but some patterns make the resection disproportionately risky for the donor, and that is a legitimate reason to decline.
Step 4: Medical fitness
The donor is, by definition, a healthy person being asked to undergo major abdominal surgery for someone else’s benefit. Evaluation covers heart, lungs, kidneys and liver function, metabolic health, and the absence of any condition that would make a long anaesthetic and a major resection disproportionately dangerous for a person who has no disease of their own.
Step 5: Psychological and social assessment — independent of the recipient’s team
Every living donor is assessed to confirm the decision is voluntary and not the product of family pressure or guilt. This assessment is deliberately kept independent of the recipient’s care team, so a donor who has doubts has a safe, private room in which to raise them. The questions are simple. Do they understand the risks? Is this an informed decision? Do they feel free to decline? Is anyone pressuring them? Are their expectations of recovery realistic?
A willing donor is not automatically a suitable one. Someone who says “I have no choice” or “my family expects this of me” needs more support and more careful assessment. Living donation has to be voluntary, not merely offered.
| Step | What is checked | What we are looking for | Whom it protects |
|---|---|---|---|
| 1. Blood group | ABO type of donor and recipient | Identical or compatible; if not, eligibility for an ABO-incompatible protocol or a swap with another family | Recipient (rejection risk) |
| 2. Volume | CT volumetry of the whole liver and each lobe | Graft ≥0.8% of recipient body weight; donor remnant ≥30% of their own liver (some programmes set higher bars) | Both — small graft harms the recipient, small remnant harms the donor |
| 3. Liver quality | Liver tests, MRI fat quantification, biopsy if needed; CT/MRCP vascular and biliary anatomy | No more than mild steatosis (thresholds vary by programme); anatomy that allows a safe resection | Both |
| 4. Medical fitness | Cardiac, pulmonary, renal and metabolic work-up; viral markers | No condition that makes a long anaesthetic and major surgery disproportionately risky for a healthy person | Donor |
| 5. Psychological and social | Interview by a clinician independent of the recipient’s team | An informed, voluntary decision, free of pressure or guilt, with realistic expectations | Donor |
| Then the law | Hospital or state authorisation committee | Relationship confirmed, no commercial motive — see the donor eligibility post | Both, and the system |
Who is most likely to be a match for a liver transplant?
Blood group is the easy part patients fixate on. The person most likely to come through evaluation as a match is an adult in good general health, with a compatible blood group or access to an incompatible protocol, a liver large enough for the recipient and for themselves, little or no liver fat, favourable vascular and biliary anatomy, a genuine understanding of the operation and the recovery, and the freedom to decide without pressure. Notice what is not on that list: being the closest relative, being the most willing, or being the youngest.
Does age matter?
Age is a factor, not the deciding one. Most donors fall within the conventional range transplant programmes use — the Tokyo criteria, for instance, accept 20 to 65 — but chronological age is only part of the picture. In practice I have cleared a handful of carefully selected donors up to 58 years old: highly motivated people, never routine decisions, each of whom went through extended evaluation of liver quality, cardiovascular fitness, metabolic health and overall surgical risk before being accepted. The published evidence supports this. A Korean series comparing 42 right-lobe donors aged 55 and over with 498 younger donors — all held to a remnant of at least 30% and no more than mild fatty liver — found no difference in donor complications or in one-year graft and patient survival.
Counselling an older donor is deliberately different from counselling a younger one. More time goes to the additional uncertainties that come with age, the likelihood of a slower recovery, and making sure the donor genuinely understands both benefit and risk, with no pressure to proceed. When evaluation confirms safety, age alone should not close the door on a family’s ability to help.
Equally clear: enthusiasm alone is never enough. Significant fatty liver, cardiovascular disease, or diabetes with end-organ damage — any factor pushing donor risk past an acceptable threshold — means advising against donation regardless of age. We do not select the youngest donor; we select the safest one. Sometimes that is a 25-year-old. Sometimes it is a 58-year-old. Biology and risk decide it, not the number on the identity card.
Case: when the obvious choice was not the right one
A middle-aged man with decompensated cirrhosis needed urgent transplant evaluation. The moment his family understood a living donor transplant was possible, his eldest daughter volunteered — no hesitation. “If my father needs my liver, I’ll do it.” The family assumed the search was over.
As part of the routine donor work-up she went through blood tests, imaging and a detailed liver assessment. Young, healthy, highly motivated — and her CT scan showed significant fatty liver. Donating would have raised her own risk without guaranteeing an adequate graft for her father.
That was a hard conversation. She felt she had failed him. We spent time making one thing clear: donor selection is never a measure of love or commitment. It is a measure of safety. The evaluation was never looking for someone willing — it was looking for someone who could donate safely.
The family then agreed to evaluate other relatives. Her younger paternal uncle — who had stayed in the background, assuming the younger generation would step forward — turned out to have excellent liver health, favourable anatomy and appropriate liver volume. He became the donor. Both operations went well; the recipient recovered, and the donor returned to normal life after rehabilitation.
Months later the daughter told me that understanding why she had been declined had lifted the guilt she had been carrying. Being turned down as a donor did not mean she had done less for her father. Supporting him through recovery mattered just as much.
Case: an ABO-incompatible wife donor in acute-on-chronic liver failure
A 55-year-old man presented with acute-on-chronic liver failure, deteriorating rapidly — the kind of presentation where the decision window can be as tight as two to three days. His wife came forward as donor. She was not a blood-group match. The transplant proceeded as ABO-incompatible, within the selected-cohort protocol described above. Early recognition and early transplant — not waiting for a “perfect” match while he deteriorated further — was what made survival possible.
One honest caveat from the literature: a standard desensitisation course needs around two to three weeks, so emergency ABOi transplant in ACLF means a modified, individualised protocol, and the published evidence for that setting is still a handful of case series. It is a decision for an experienced centre, taken with the family’s eyes open.
When a willing donor is found unsuitable
This happens, and how it is handled matters as much as the medical finding itself.
My approach: I start by thanking them directly for their generosity — stepping forward at all is not a small thing. Then I am direct: a thorough evaluation has determined we cannot safely proceed, because donor safety is the absolute priority in this field, full stop. I make a point of clarifying that this is not a verdict on their general health. It means their specific anatomy, or liver, is not suited to the extreme demands of donation — a narrow technical finding, not a judgement of them as a person. It is difficult news to deliver and to hear, but protecting a healthy person’s long-term wellbeing is non-negotiable, and we move immediately to the alternatives — another relative, a swap, an incompatible protocol, or the deceased-donor list — rather than leaving the family at a dead end.
Family counselling: the part that determines whether this works
Counselling a family through an LDLT decision is one of the most delicate parts of this practice. We are no longer treating a patient alone. We are asking a perfectly healthy family member to undergo major surgery for someone else.
My responsibility in these sessions is absolute transparency: confirming the donor is stepping forward voluntarily, free of unspoken pressure or guilt; laying out the unvarnished surgical risks; the dual recovery timeline for donor and recipient; and the real emotional, physical and financial toll on the whole household. A successful LDLT needs a unified, realistic, committed family behind it — not just surgical precision in the operating theatre. No family leaves that conversation without understanding that the donor’s wellbeing is the one non-negotiable in the room.
One point of timing belongs here, because families misread it. With a living donor the recipient’s MELD score is not a queue position but a measure of surgical risk, and a patient transplanted at a moderate MELD generally does better than one who waited to become “sick enough” — I explain why in Am I a good candidate for a liver transplant?. The practical consequence is that donor evaluation should begin early, not when the patient is in intensive care. Bring your questions to your own transplant team; nothing here replaces that conversation, and no medicine should be started, stopped or altered on the strength of an article.
The right donor is not whoever offers first or loudest. It is whoever comes through a rigorous, honest evaluation as the safest match. That process can feel slow and frustrating to a family in crisis, but every step in it exists for one reason: protecting both lives on the table, not just the one already sick. A successful transplant never comes at the cost of the one who gives.
Frequently asked questions
Who is most likely to be a match for a liver transplant?
A healthy adult with a compatible blood group (or access to an ABO-incompatible protocol), a liver large enough to give the recipient a graft of at least 0.8% of their body weight while keeping at least 30% for themselves, little or no liver fat, suitable anatomy, and a genuinely voluntary decision. Being the closest relative, the most willing or the youngest does not by itself make someone the best match.
Should the spouse always be considered first?
No. The order in which people volunteer has no bearing on suitability. Each potential donor is evaluated independently against the same medical and psychological criteria, and the safest candidate is chosen.
Does the donor have to be a blood relative?
No. Spouses and, in some circumstances, unrelated donors can be evaluated, subject to the same medical criteria and to India’s legal framework and authorisation committee process. Published Indian data suggest biologically related donors do marginally better in ABO-incompatible transplants, but a compatible spouse is a routine and successful donor.
If we are not a blood-group match, is that the end of it?
Not necessarily. ABO-incompatible transplant with pre-operative desensitisation is an established option in selected patients, with survival in large published series comparable to compatible transplants, though with more biliary complications. A swap with another family in the same position is the other route. Ask specifically about both during evaluation.
What if the only willing donor does not pass evaluation?
The family is not left without options. Other relatives can be evaluated, a swap or an ABO-incompatible protocol may be possible, and listing for a deceased-donor organ remains open. A declined donor has not failed — the refusal exists to protect them.
Can more than one person be evaluated at once?
Yes. When several family members come forward, each goes through independent assessment on the same criteria, and evaluating two or three in parallel is often the fastest way to find the safest donor for a patient who cannot wait.
Book a consultation with Dr Chetan Kalal at Gleneagles Hospital, Mumbai — call +91 83294 76669 or use the appointment form on this site. International and NRI patients may request a teleconsultation.
References
- Narasimhan G. Living donor liver transplantation in India. Hepatobiliary Surg Nutr. 2016;5(2):127–132. PMID 27115006. doi:10.3978/j.issn.2304-3881.2015.09.01
- Kow AWC, Liu J, Patel MS, et al. Post living donor liver transplantation small-for-size syndrome: definitions, timelines, biochemical, and clinical factors for diagnosis: guidelines from the ILTS-iLDLT-LTSI Consensus Conference. Transplantation. 2023;107(10):2226–2237. PMID 37749812. doi:10.1097/TP.0000000000004770
- Reddy MS, Rammohan A, Gupta S, et al. International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation. Am J Transplant. 2024;24(12):2246–2257. PMID 38914281. doi:10.1016/j.ajt.2024.06.013
- Akamatsu N, Kokudo N. Living liver donor selection and resection at the University of Tokyo Hospital. Transplant Proc. 2016;48(4):998–1002. PMID 27320541. doi:10.1016/j.transproceed.2016.01.019
- Kim SH, Lee EC, Shim JR, Park SJ. Right lobe living donors ages 55 years old and older in liver transplantation. Liver Transpl. 2017;23(10):1305–1311. PMID 28734130. doi:10.1002/lt.24823
- Song GW, Lee SG, Hwang S, et al. ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab. Am J Transplant. 2016;16(1):157–170. PMID 26372830. doi:10.1111/ajt.13444
- Yadav DK, Hua YF, Bai X, et al. ABO-incompatible adult living donor liver transplantation in the era of rituximab: a systematic review and meta-analysis. Gastroenterol Res Pract. 2019;2019:8589402. PMID 31285743. doi:10.1155/2019/8589402
- Ranjan P, Pathak N, Gupta S, Agarwal S. Improved outcomes of ABO-incompatible living donor liver transplant with biologically related donors. Liver Transpl. 2024;30(12):1273–1280. PMID 39018049. doi:10.1097/LVT.0000000000000438
- Jadaun SS, Agarwal S, Gupta S, Saigal S. Strategies for ABO incompatible liver transplantation. J Clin Exp Hepatol. 2023;13(4):698–706. PMID 37440942. doi:10.1016/j.jceh.2022.12.008
- Ghosh NK, Makki K, Yadav Y, et al. Tailored strategies for emergency ABO-incompatible living donor liver transplantation: a series of three cases. Clin Transplant Res. 2025;39(2):161–168. PMID 39962808. doi:10.4285/ctr.24.0061
- Kute VB, Patel HV, Banerjee S, et al. Analysis of kidney and liver exchange transplantation in India (2000–2025): a multicentre, retrospective cohort study. Lancet Reg Health Southeast Asia. 2025;37:100597. PMID 40502860. doi:10.1016/j.lansea.2025.100597
